Intended for US audience onlyIntended for US audience only

You are now leaving MyGARDian.com website

Stay on MyGARDian.com Continue

Baxter is not responsible for the privacy policy, the content or the accuracy of any website accessed through a link on the myGARDian.com site. A link to other websites does not constitute an endorsement by Baxter of the linked site, its products or services.

The browser window or tab for myGARDian.com will remain open underneath the new browser window or tab. To return to myGARDian.com at any time, close this tab or window.

Online Insurance Resources

These websites contain information that may be useful in identifying and understanding insurance issues pertaining to primary immunodeficiency disease and IgG.

These links are provided for your convenience. Baxter Healthcare Corporation does not possess editorial control over the content or the information on third party sites. As such, Baxter Healthcare Corporation and the compiler of the list make no representation as to the accuracy, completeness, and any other aspect of the information contained in those sites.

Important Risk Information for GAMMAGARD LIQUID

In clinical trials, two serious events (two episodes of aseptic meningitis in one patient) were deemed to be possibly related to the infusion of GAMMAGARD LIQUID. Various mild and moderate reactions, such as headache, fever, fatigue, chills, flushing, dizziness, urticaria, wheezing or chest tightness, nausea, vomiting, rigors, back pain, chest pain, muscle cramps, and changes in blood pressure may occur with infusions of GAMMAGARD LIQUID.

Please see the detailed Important Risk Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] for full prescribing details.

Need Help Tracking Infusions?

Get organized. Track infusions. Take control. Order your complimentary 2011 Wellness Kit today!

Order Your Kit